Criminal Code Amendment Regulation 2010 (No 1) (ACT)
Criminal Code Amendment Regulation 2010 (No 1)
Subordinate Law SL2010-41
The Australian Capital Territory Executive makes the following regulation under the Criminal Code 2002.
Dated 19 October 2010.
Simon Corbell
Minister
Katy Gallagher
Minister
Criminal Code Amendment Regulation 2010 (No 1)
Subordinate Law SL2010-41
made under the
Criminal Code 2002
Contents
Page
Name of regulation 1
Commencement 1
Legislation amended 1
Section 5 1
Section 7 2
Section 8 (2) 3
New section 8 (5) and (6) 5
Schedule 1, part 1.2, new item 14A 6
Schedule 1, part 1.2, new item 98A 6
Schedule 1, part 1.2, new item 132A 6
Schedule 3 6
Dictionary, definition of associated drug 11
Dictionary, new definition of derivative 11
Dictionary, definition of related drug 11
Name of regulation
This regulation is the Criminal Code Amendment Regulation 2010 (No 1).
Commencement
This regulation commences on the day after its notification day.
NoteThe naming and commencement provisions automatically commence on the notification day (see Legislation Act, s 75 (1)).
Legislation amended
This regulation amends the Criminal Code Regulation 2005.
Section 5
substitute
Controlled drugs—Code, s 600, def controlled drug
(1)A substance mentioned in schedule 1 is prescribed.
(2)The following substances (each of which is a related drug) are also prescribed:
(a)a form of a drug mentioned in schedule 1, whether natural or synthetic, and the salts, derivatives and isomers of that drug and any salt of those derivatives and isomers;
(b)a drug that is in a class of drugs mentioned in schedule 1, whether natural or synthetic, and the salts, derivatives and isomers of that drug and any salt of those derivatives and isomers;
(c)an analogue in relation to a drug mentioned in schedule 1, which includes any substance having a substantially similar chemical structure to the drug, but differing in elemental composition due to the addition, deletion or replacement of any substituent element or group;
(d)a homologue in relation to a drug mentioned in schedule 1, which includes any substance which differs from that drug by one or more carbon containing groups (including methylene groups) in that chemical structure;
(e)a substance containing or mixed with a substance mentioned in schedule 1.
Section 7
substitute
Controlled precursors—Code, s 600, def controlled precursor
(1)A substance mentioned in schedule 3 is prescribed.
(2)The following substances (each of which is a related precursor) are also prescribed:
(a)a preparation, admixture, extract or other substance containing any proportion of a substance mentioned in schedule 3;
(b)a substance that is 1 of the following in relation to a substance mentioned in schedule 3:
(i)acetal;
(ii)acetate;
(iii)acid chloride;
(iv)amide;
(v)anhydride;
(vi)diol;
(vii)epoxide;
(viii)ester;
(ix)ether;
(x)halogen substituent;
(xi)hydroxide;
(xii)imine;
(xiii)isomer;
(xiv)ketal;
(xv)nitrile;
(xvi)oxime;
(xvii)salt;
(c)any other analogue or derivative of a substance mentioned in schedule 3.
Section 8 (2)
substitute
(2)For a related drug—
(a)a trafficable quantity is the quantity mentioned in schedule 1, column 3 for—
(i)the drug to which it is related; or
(ii)if it is related to more than 1 drug—the drug to which it is related that has the smallest quantity mentioned in schedule 1, column 3; and
(b)a commercial quantity is the quantity mentioned in schedule 1, column 4 for—
(i)the drug to which it is related; or
(ii)if it is related to more than 1 drug—the drug to which it is related that has the smallest quantity mentioned in schedule 1, column 3; and
(c)a large commercial quantity is the quantity mentioned in schedule 1, column 5 for—
(i)the drug to which it is related; or
(ii)if it is related to more than 1 drug—the drug to which it is related that has the smallest quantity mentioned in schedule 1, column 3.
Example—par (a) (ii), par (b) (ii) and par (c) (ii)
Drug X is a related drug that is related to—
· Morphine (sch 1, pt 1.1, item 49); and
· Pethidine (sch 1, pt 1.1, item 60).
In sch 1, col 3, the quantity for Morphine is 2.00g and the quantity for Pethidine is 10.00g. Because the Morphine quantity is smaller than the Pethidine quantity, Morphine is the relevant drug for working out the quantities for drug X. Therefore, a trafficable quantity of drug X is 2.00g, a commercial quantity of drug X is 0.75kg and a large commercial quantity of drug X is 1.50kg.
NoteAn example is part of the regulation, is not exhaustive and may extend, but does not limit, the meaning of the provision in which it appears (see Legislation Act, s 126 and s 132).
New section 8 (5) and (6)
insert
(5)For a related precursor—
(a)a commercial quantity is the quantity mentioned in schedule 3, column 3 for—
(i)the precursor to which it is related; or
(ii)if it is related to more than 1 precursor—the precursor to which it is related that has the smallest quantity mentioned in schedule 3, column 3; and
(b)a large commercial quantity is the quantity mentioned in schedule 3, column 4 for—
(i)the precursor to which it is related; or
(ii)if it is related to more than 1 precursor—the precursor to which it is related that has the smallest quantity mentioned in schedule 3, column 3.
Example—par (a) (ii) and par (b) (ii)
Precursor X is a related precursor that is related to—
· Ammonia (sch 3, item 8); and
· Calcium (sch 3, item 20).
In sch 3, col 3, the quantity for Ammonia is 1.50kg and the quantity for Calcium is 0.25kg. Because the Calcium quantity is smaller than the Ammonia quantity, Calcium is the relevant precursor for working out the quantities for precursor X. Therefore, a commercial quantity of precursor X is 0.25kg and a large commercial quantity of precursor X is 0.50kg.
NoteAn example is part of the regulation, is not exhaustive and may extend, but does not limit, the meaning of the provision in which it appears (see Legislation Act, s 126 and s 132).
(6)In this section:
related drug—see section 5 (2).
related precursor—see section 7 (2).
Schedule 1, part 1.2, new item 14A
insert
| 14A | Benzylpiperazine (BZP) | 2.00 | 1.00 | 2.00 |
Schedule 1, part 1.2, new item 98A
insert
| 98A | N,N-dimethylamphetamine | 2.00 | 1.00 | 2.00 |
Schedule 1, part 1.2, new item 132A
insert
| 132A | Trifluoromethylphenylpiperazine (TFMPP) | 2.00 | 1.00 | 2.00 |
Schedule 3
substitute
Schedule 3Controlled precursors
(see s 7, s 8 (4), (5) and (6))
| column 1 item | column 2 controlled precursor | column 3 commercial quantity | column 4 large commercial quantity |
| 1 | Acetaldehyde | 0.50kg | 1.00kg |
| 2 | Acetic anhydride | 0.70kg | 1.50kg |
| 3 | N-Acetylanthranilic acid | 5.00kg | 10.00kg |
| 4 | Allylbenzene | 0.25L | 0.50L |
| 5 | Allylpyrocatechol | 0.10L | 0.20L |
| 6 | Alpha-phenylacetoacetonitrile | 0.50kg | 1.00kg |
| 7 | 4-Amino-butanoic acid | 1.50kg | 3.00kg |
| 8 | Ammonia | 1.50kg | 3.00kg |
| 9 | Ammonium formate | 0.50kg | 1.00kg |
| 10 | Anthranilic acid | 5.00kg | 10.00kg |
| 11 | Benzaldehyde | 0.50L | 1.00L |
| 12 | 1,3-Benzodioxole | 0.25L | 0.50L |
| 13 | Benzyl bromide | 0.50L | 1.00L |
| 14 | Benzyl chloride | 0.50L | 1.00L |
| 15 | Boron tribromide | 0.25L | 0.50L |
| 16 | Bromobenzene | 1.05kg | 2.10kg |
| 17 | 5-Bromo-1,3-benzodioxole | 0.25L | 0.50L |
| 18 | Bromo safrole | 0.30kg | 0.60kg |
| 19 | 1,4-Butanediol | 1.50L | 3.00L |
| 20 | Calcium | 0.25kg | 0.50kg |
| 21 | 1-Chlorophenyl-2-aminopropane | 1.25kg | 2.50kg |
| 22 | Chromic acid | 0.10L | 0.20L |
| 23 | Chromium trioxide | 0.10kg | 0.20kg |
| 24 | Ephedrine | 0.25kg | 0.50kg |
| 25 | Ergometrine | 0.0001kg | 0.0002kg |
| 26 | Ergotamine | 0.0002kg | 0.0004kg |
| 27 | Ethanamine | 0.50L | 1.00L |
| 28 | Ethyl phenyl acetate | 0.50kg | 1.00kg |
| 29 | N-Ethylephedrine | 0.25kg | 0.50kg |
| 30 | N-Ethylpseudoephedrine | 0.25kg | 0.50kg |
| 31 | Eugenol | 0.10L | 0.20L |
| 32 | Formaldehyde | 1.50kg | 3.00kg |
| 33 | Formamide | 0.50L | 1.00L |
| 34 | Gamma butyrolactone | 1.50L | 3.00L |
| 35 | Gamma hydroxybutanoic acid | 1.50L | 3.00L |
| 36 | Hydriodic acid | 0.65L | 1.70L |
| 37 | Hydrobromic acid | 0.25L | 0.50L |
| 38 | Hydrogen | 1.50kg | 3.00kg |
| 39 | Hydrogen chloride | 1.50kg | 3.00kg |
| 40 | Hydrogen sulfide | 1.50kg | 3.00kg |
| 41 | 4-Hydroxybutanal | 1.50L | 3.00L |
| 42 | 4-Hydroxy-butanoic acid lactone | 1.50L | 3.00L |
| 43 | 4-Hydroxy-butanoic acid nitrile | 1.50L | 3.00L |
| 44 | 4-Hydroxy pentanoic acid | 1.50L | 3.00L |
| 45 | 2-Hydroxytetrahydrofuran | 1.50L | 3.00L |
| 46 | Hypophosphite salts | 0.25 kg | 0.50kg |
| 47 | Hypophosphorous acid | 0.45L | 0.90L |
| 48 | Iodine | 0.25kg | 0.50kg |
| 49 | Isosafrole | 0.30L | 0.60L |
| 50 | Lithium | 0.25kg | 0.50kg |
| 51 | Lithium aluminium hydride | 0.05kg | 0.10kg |
| 52 | Lysergic acid | 0.00005kg | 0.0001kg |
| 53 | Magnesium | 0.25kg | 0.50kg |
| 54 | Mandellic acid | 0.50kg | 1.00kg |
| 55 | Mercuric chloride | 0.001kg | 0.002kg |
| 56 | Mercury | 0.001kg | 0.002kg |
| 57 | Methcathinone | 0.25kg | 0.50kg |
| 58 | Methylamine | 0.50L | 1.00L |
| 59 | Methylammonium salts | 0.25kg | 0.50kg |
| 60 | 3,4-Methylenedioxyphenylacetic acid | 0.10kg | 0.20kg |
| 61 | 3,4-Methylenedioxyphenylpropan-2-one (PMK) | 0.05kg | 0.10kg |
| 62 | N-Methylformamide | 0.50L | 1.00L |
| 63 | N-Methyl ephedrine | 1.20kg | 2.40kg |
| 64 | Methyl phenylacetate | 1.00kg | 2.00kg |
| 65 | N-Methylpseudoephedrine | 1.20kg | 2.40kg |
| 66 | Methylstyrene | 0.50L | 1.00L |
| 67 | Nitroethane | 0.50L | 1.00L |
| 68 | Nitromethane | 0.50L | 1.00L |
| 69 | Norpseudoephedrine | 2.15kg | 4.30kg |
| 70 | Palladium | 0.005kg | 0.01kg |
| 71 | Phenylacetamide | 0.50kg | 1.00kg |
| 72 | Phenylacetic acid | 0.50kg | 1.00kg |
| 73 | Phenylacetonitrile | 1.45L | 2.90L |
| 74 | Phenylacetyl chloride | 1.05L | 2.10L |
| 75 | Phenylalanine | 0.50kg | 1.00kg |
| 76 | 1-Phenyl-2-bromopropane | 0.50kg | 1.00kg |
| 77 | 1-Phenyl-2-chloropropane | 1.15kg | 2.30kg |
| 78 | 1-Phenyl-2-iodopropane | 0.50kg | 1.00kg |
| 79 | 1-Phenyl-2-nitropropene | 1.20kg | 2.40kg |
| 80 | Phenylpropanolamine | 2.15kg | 4.30kg |
| 81 | 1-Phenyl-2-propanol | 0.90L | 1.80L |
| 82 | 1-Phenyl-1-propanone | 0.25L | 0.50L |
| 83 | 1-Phenyl-2-propanone (BMK) | 1.00L | 2.00L |
| 84 | 1-Phenyl-2-propanone oxime | 1.00kg | 2.00kg |
| 85 | Phosphorus | 0.10kg | 0.20kg |
| 86 | Phosphorous acid | 1.10L | 2.20L |
| 87 | Piperidine | 0.35kg | 0.70kg |
| 88 | Piperonal | 0.30kg | 0.60kg |
| 89 | Platinum | 0.005kg | 0.010kg |
| 90 | Potassium | 0.25kg | 0.50kg |
| 91 | Propionic anhydride | 0.05L | 0.10L |
| 92 | Pseudoephedrine | 1.10kg | 2.20kg |
| 93 | Pyridine | 1.00L | 2.00L |
| 94 | 2-Pyrrolidone | 1.50L | 3.00L |
| 95 | Raney nickel | 0.05kg | 0.10kg |
| 96 | Safrole | 0.30L | 0.60L |
| 97 | Sassafras oil | 0.10L | 0.20L |
| 98 | Sodium | 0.25kg | 0.50kg |
| 99 | Sodium bis (2-methoxyethoxy) aluminium hydride | 0.05kg | 0.10kg |
| 100 | Sodium borohydride | 0.05kg | 0.10kg |
| 101 | Sodium cyanoborohydride | 0.05kg | 0.10kg |
| 102 | Thionyl chloride | 0.25kg | 0.50kg |
| 103 | Thorium | 1.00kg | 2.00kg |
Dictionary, definition of associated drug
omit
Dictionary, new definition of derivative
insert
derivative means a substance or compound made from another substance or compound.
Dictionary, definition of related drug
omit
Endnotes
Notification
Notified under the Legislation Act on 25 October 2010.
Republications of amended laws
For the latest republication of amended laws, see align="center">© Australian Capital Territory 2010
0
0
0